: The hepatitis B virus's (HBV) capability to mutate genetically poses a threat to the sensitivity of serological and genomic diagnostics. As a result the knowledge about the distribution of HBV genotypes (GENs) and mutation has a significant impact on treatment plans, immunisation campaigns, treatment, and prophylaxis of HBV. : The objective of our study was to identify HBV Genotypes in HBsAg-positive individuals. : The study was conducted on 117 HBsAg-positive patients who showed the presence of the S gene were subjected to DNA extraction. The extracted DNA was amplified by Nested PCR (Polymerase Chain Reaction) followed by RFLP (Restriction fragment length polymorphism). : Out of 117 patients, 84% were genotype D and 16 % were genotype A. More patients of Genotype A had a fever and Jaundice (15.7%; 21 vs 5%; 13.2%) as compared to Genotype D. In this study 19.6% of patients were in the immune clearance phase, 18% in the inactive carrier, 6% in immune tolerance phase. : A better understanding of the prevalence, diagnostic, and serologic patterns of hepatitis B in this region can aid practitioners in recommending appropriate antivirals by genetic data.
No takes yet. Share an insight, caveat, or question.
Naz et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: